Literature DB >> 2228923

Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings.

K D Gadow1, E E Nolan, J Sverd, J Sprafkin, L Paolicelli.   

Abstract

One of the least documented "known" effects of methylphenidate in hyperactive children is the suppression of peer aggression. In this study, 11 aggressive-hyperactive children received a low (0.3 mg/kg) and moderate (0.6 mg/kg) dose of methylphenidate and placebo for 2 weeks each under double-blind conditions. Children were observed in public school settings during classroom seatwork activities, lunch, and recess. Results showed that methylphenidate suppressed nonphysical aggression (p = 0.06) in the classroom, and a moderate dose decreased physical aggression (p less than 0.01) and verbal aggression (p = 0.07) on the playground. The effect on the rate of appropriate social interaction was variable. The majority of subjects exhibited either the same or higher levels of appropriate social interaction on the 0.6 mg/kg dose compared with placebo. In the classroom, both doses of methylphenidate also resulted in reduced levels of motor movement, off-task behavior, noncompliance, and disruptiveness. Teacher ratings of hyperactivity and conduct problem symptoms revealed drug effects, whereas parallel parent instruments did not.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228923     DOI: 10.1097/00004583-199009000-00006

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  17 in total

Review 1.  Toward a transactional conceptualization of oppositional defiant disorder: implications for assessment and treatment.

Authors:  R W Greene; A E Doyle
Journal:  Clin Child Fam Psychol Rev       Date:  1999-09

Review 2.  Therapeutics of aggression in children.

Authors:  D S Pine; E Cohen
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

4.  Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Authors:  Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Robert L Findling; Oscar G Bukstein; Nicole V Brown; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi L Kipp; Jayne Schneider; Cristan A Farmer; Jennifer L Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Eric M Butter; Kristin A Buchan-Page; Elizabeth A Hurt; Adrienne B Austin; Sabrina N Grondhuis; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-12       Impact factor: 8.829

Review 5.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 6.  Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Authors:  Jonathan Ipser; Dan J Stein
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

7.  Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior.

Authors:  Joseph C Blader
Journal:  J Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.153

Review 8.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

9.  Perceptions of methylphenidate effects on hyperactive children's peer interactions.

Authors:  D A Granger; C K Whalen; B Henker
Journal:  J Abnorm Child Psychol       Date:  1993-10

Review 10.  The Good Behavior Game: a best practice candidate as a universal behavioral vaccine.

Authors:  Dennis D Embry
Journal:  Clin Child Fam Psychol Rev       Date:  2002-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.